The Definitive Guide to Bevacizumab
Sufferers with Hepatic Impairment: No information about dose adjustment is provided during the manufacturer's labeling. Based on the literature critique, no dose adjustment is likely desired in hepatic impairment.[seventeen]Bevacizumab was originally derived from a mouse monoclonal antibody created from mice immunized Together with the one hundred